OFI Invest Asset Management Cuts Position in Danaher Corporation $DHR

OFI Invest Asset Management lessened its stake in Danaher Corporation (NYSE:DHR) by 54.7% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 502 shares of the conglomerate’s stock after selling 606 shares during the quarter. OFI Invest Asset Management’s holdings in Danaher were worth $99,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in DHR. GHP Investment Advisors Inc. increased its holdings in shares of Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock valued at $25,000 after purchasing an additional 99 shares in the last quarter. Sierra Ocean LLC increased its holdings in shares of Danaher by 116.9% in the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock valued at $29,000 after purchasing an additional 76 shares in the last quarter. Red Tortoise LLC increased its holdings in shares of Danaher by 175.0% in the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock valued at $30,000 after purchasing an additional 98 shares in the last quarter. Smallwood Wealth Investment Management LLC purchased a new position in shares of Danaher in the 1st quarter valued at about $31,000. Finally, Dunhill Financial LLC increased its holdings in shares of Danaher by 68.4% in the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate’s stock valued at $34,000 after purchasing an additional 67 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insider Buying and Selling

In related news, Director Teri List sold 2,778 shares of the company’s stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the transaction, the director owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 11.10% of the company’s stock.

Danaher Stock Performance

NYSE:DHR opened at $202.53 on Monday. The firm has a 50 day simple moving average of $200.66 and a 200-day simple moving average of $197.07. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. The firm has a market cap of $145.02 billion, a PE ratio of 43.09, a P/E/G ratio of 2.88 and a beta of 0.77. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $279.41.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating analysts’ consensus estimates of $1.64 by $0.16. The business had revenue of $5.94 billion during the quarter, compared to analyst estimates of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company’s revenue was up 3.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, equities analysts expect that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be given a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 annualized dividend and a yield of 0.6%. Danaher’s dividend payout ratio is 27.23%.

Analyst Ratings Changes

Several equities analysts have weighed in on DHR shares. Royal Bank Of Canada set a $241.00 target price on shares of Danaher in a report on Tuesday, September 2nd. Rothschild & Co Redburn reaffirmed a “neutral” rating and issued a $220.00 price target (down previously from $245.00) on shares of Danaher in a report on Wednesday, October 8th. Guggenheim reaffirmed a “buy” rating and issued a $250.00 price target on shares of Danaher in a report on Wednesday, July 23rd. Evercore ISI upped their price target on shares of Danaher from $226.00 to $245.00 and gave the company an “outperform” rating in a report on Tuesday, October 7th. Finally, Rothschild Redb downgraded shares of Danaher from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 8th. Seventeen equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $244.60.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.